Paper24039628
Modulating the tumor immune microenvironment as an ovarian cancer treatment strategy.
Scarlett UK and 1 other. Expert Rev Obstet Gynecol, 2012. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Modulating the tumor immune microenvironment as an ovarian cancer treatment strategy. Papers, record 24039628. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24039628
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| F31 CA134188 | NCI NIH HHS | United States | F31CA134188 | PubMed and NIH | NIH RePORTER |
| R01 CA124515 | NCI NIH HHS | United States | R01CA124515 | PubMed and NIH | NIH RePORTER |
| R01 CA157664 | NCI NIH HHS | United States | R01CA157664 | PubMed and NIH | NIH RePORTER |
| U54 CA151662 | NCI NIH HHS | United States | U54CA151662 | PubMed and NIH | NIH RePORTER |
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22307839 | Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer. | Cancer Res | 2012 | https://conductscience.org/library/papers/22307839 | PubMed |
| 2 | 8420671 | Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality. | Cancer | 1993 | https://conductscience.org/library/papers/8420671 | PubMed |
| 3 | 22418702 | Mesothelin, a novel immunotherapy target for triple negative breast cancer. | Breast Cancer Res Treat | 2012 | https://conductscience.org/library/papers/22418702 | PubMed |
| 4 | 21941296 | The parallel lives of angiogenesis and immunosuppression: cancer and other tales. | Nat Rev Immunol | 2011 | https://conductscience.org/library/papers/21941296 | PubMed |
| 5 | 18157142 | Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. | Nat Med | 2008 | https://conductscience.org/library/papers/18157142 | PubMed |
| 6 | 17360651 | Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17360651 | PubMed |
| 7 | 9377574 | Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. | Cancer Res | 1997 | https://conductscience.org/library/papers/9377574 | PubMed |
| 8 | 15007094 | Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN. | J Exp Med | 2004 | https://conductscience.org/library/papers/15007094 | PubMed |
| 9 | 21436454 | CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. | Science | 2011 | https://conductscience.org/library/papers/21436454 | PubMed |
| 10 | 22065722 | A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment. | Cancer Res | 2012 | https://conductscience.org/library/papers/22065722 | PubMed |
| 11 | 19738057 | In situ stimulation of CD40 and Toll-like receptor 3 transforms ovarian cancer-infiltrating dendritic cells from immunosuppressive to immunostimulatory cells. | Cancer Res | 2009 | https://conductscience.org/library/papers/19738057 | PubMed |
| 12 | 12529460 | Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. | N Engl J Med | 2003 | https://conductscience.org/library/papers/12529460 | PubMed |
| 13 | 16120050 | Immunotherapy for gynaecological malignancies. | Expert Opin Biol Ther | 2005 | https://conductscience.org/library/papers/16120050 | PubMed |
| 14 | 20605485 | Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. | Immunity | 2010 | https://conductscience.org/library/papers/20605485 | PubMed |
| 15 | 22351743 | Mesothelin-targeted agents in clinical trials and in preclinical development. | Mol Cancer Ther | 2012 | https://conductscience.org/library/papers/22351743 | PubMed |
| 16 | 21113407 | CD277 is a negative co-stimulatory molecule universally expressed by ovarian cancer microenvironmental cells. | Oncotarget | 2010 | https://conductscience.org/library/papers/21113407 | PubMed |
| 17 | 19474385 | Cancer statistics, 2009. | CA Cancer J Clin | 2009 | https://conductscience.org/library/papers/19474385 | PubMed |
| 18 | 20400704 | CD4+ T cells elicit host immune responses to MHC class II-negative ovarian cancer through CCL5 secretion and CD40-mediated licensing of dendritic cells. | J Immunol | 2010 | https://conductscience.org/library/papers/20400704 | PubMed |
| 19 | 21957230 | Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death. | J Natl Cancer Inst | 2011 | https://conductscience.org/library/papers/21957230 | PubMed |
| 20 | 15334073 | Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. | Nat Med | 2004 | https://conductscience.org/library/papers/15334073 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37760595 | Specific Tumor Localization of Immunogenic Lipid-Coated Mesoporous Silica Nanoparticles following Intraperitoneal Administration in a Mouse Model of Serous Epithelial Ovarian Cancer. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37760595 | PubMed |
| 36741442 | Cytoplasmic p53 aggregates accumulated in p53-mutated cancer correlate with poor prognosis. | PNAS Nexus | 2022 | https://conductscience.org/library/papers/36741442 | PubMed |
| 35155439 | Prognostic Value and Therapeutic Potential of CBX Family Members in Ovarian Cancer. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/35155439 | PubMed |
| 33800608 | Chimeric Antigen Receptor Design and Efficacy in Ovarian Cancer Treatment. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33800608 | PubMed |
| 32850861 | Tumor Microenvironment in Ovarian Cancer: Function and Therapeutic Strategy. | Front Cell Dev Biol | 2020 | https://conductscience.org/library/papers/32850861 | PubMed |
| 32059873 | Induction of antitumor immunity in mice by the combination of nanoparticle-based photothermolysis and anti-PD-1 checkpoint inhibition. | Nanomedicine | 2020 | https://conductscience.org/library/papers/32059873 | PubMed |
| 29338446 | The latest animal models of ovarian cancer for novel drug discovery. | Expert Opin Drug Discov | 2018 | https://conductscience.org/library/papers/29338446 | PubMed |
| 27622059 | Immune checkpoint blockade reveals the stimulatory capacity of tumor-associated CD103(+) dendritic cells in late-stage ovarian cancer. | Oncoimmunology | 2016 | https://conductscience.org/library/papers/27622059 | PubMed |
| 27076627 | VEGF Potentiates GD3-Mediated Immunosuppression by Human Ovarian Cancer Cells. | Clin Cancer Res | 2016 | https://conductscience.org/library/papers/27076627 | PubMed |
| 26150590 | M-Trap: Exosome-Based Capture of Tumor Cells as a New Technology in Peritoneal Metastasis. | J Natl Cancer Inst | 2015 | https://conductscience.org/library/papers/26150590 | PubMed |
| 25502429 | New ways to successfully target tumor vasculature in ovarian cancer. | Curr Opin Obstet Gynecol | 2015 | https://conductscience.org/library/papers/25502429 | PubMed |
Genes29
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24039628
GET https://conductscience.org/api/papers/v1/24039628/references?page=2